Urology Market Size, Share & Trends Analysis | Japan | 2020-2026 | MedSuite | Includes: Urinary Incontinence Market, Pelvic Organ Prolapse Repair Market, and 3 more

  • Year: 2020
  • Scope: 10 Years
  • Region: Japan
  • Pages: 369
  • Published Date: 11/08/2019
  • Type: MedSuite

In 2020, the urological device market size in Japan was valued at $383 million, with over 540,000 urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.3% to reach $480 million in 2026.

Throughout this medical market research, we analyzed 31 urology companies across Japan and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the Japanese Urological Device market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.


  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Urology Procedure Volumes
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Urological Device market
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

The stone management device market, BPH treatment market and urinary incontinence management device market accounted for the vast majority of the total market in 2019. The growth in these segments is driven by the stable demand for related procedures and the increasing prevalence of prostatic and kidney diseases, fueled by the aging population of Japan. The rapidly growing aging population of the region is forcing structural changes in the market, due to the increasing prevalence of chronic and age-related diseases.

Japan Urological Devices Market Size by Segment, 2016-2026

The female urinary incontinence sling market is undergoing structural changes, due to global regulatory changes regarding transvaginal tape and mini-slings. In April 2019, the U.S. Food and Drug Administration (FDA) ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop selling and distributing their products immediately. This resulted in a significant decline of the urinary incontinence sling market in Japan.

Competitive Analysis

Japan Urology Market Leaders

By 2020, the leading competitors in the urological device market included Lumenis, Boston Scientific, and BARD, collectively representing around half of the total market value. The Japanese market is highly fragmented.

Boston Scientific’s position is secured by the company’s presence in every segment of the urological market. Lumenis is focused on laser equipment, lithotripters, and other capital equipment for stone management and BPH treatment, which were the second-largest portions of the total market. BARD dominated the urinary catheter segment, which generated the overwhelming majority of the urinary incontinence management market.

A large portion of the total market was shared by competitors with less than 10% of the total market share each. The combined urological device market is primarily defined by competitors in the stone management treatment and BPH treatment market, resulting in a strong focus on disposables and capital equipment.

Segments Covered

Click on each title to view detailed market segmentation.

  • Procedure Volumes for Urological Devices – MedPro – The complete procedural analysis of the urological device market in Japan, which includes Incontinence Sling Implantation, Artificial Urinary Sphincter Implantation, Transvaginal Tape Incontinence Sling, Transobturator Incontinence Sling, Extracorporeal Shockwave Lithotripsy, Percutaneous Nephrolithotomy procedures, and multiple others for each of the analyzed market segments.
  • Urinary Incontinence Market – MedCore – This market is further segmented into market segments, such as Urinary Catheters, Urethral Bulking Agents, and Incontinence Management device markets.
  • Pelvic Organ Prolapse Repair Market – MedCore – The market is comprised of the segments for Transvaginal and Sacrocolpopexy Meshes.
  • Stone Management Market – MedCore – This market is categorized by Device Type into ESWL Equipment, ISWL Equipment, Holmium Lasers, Stone Fragment Retrieval Device, Ureteral Stent, and Ureteral Guidewire market segments.
  • Benign Prostatic Hyperplasia (BPH) Treatment Market – MedCore – This market is segmented by Device Type, including Transurethral Resection of Prostate, Laser BPH, UroLift, and Rezūm device market segments.
  • Erectile Dysfunction Market – MedCore – The market is comprised of the segments for Inflatable, Malleable, and Vacuum devices.

Detailed Market Segmentation

Japan Urology Market Segmentation - p1Japan Urology Market Segmentation - p2


Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report


TABLE OF CONTENTS ILIST OF FIGURES XLIST OF CHARTS XIXEXECUTIVE SUMMARY 1JAPAN UROLOGICAL DEVICES MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 8MARKETS INCLUDED 9KEY REPORT UPDATES 11VERSION HISTORY 11RESEARCH METHODOLOGY 12Step 1: Project Initiation & Team Selection 12Step 2: Prepare Data Systems and Perform Secondary Research 15Step 3: Preparation for Interviews & Questionnaire Design 17Step 4: Performing Primary Research 18Step 5: Research Analysis: Establishing Baseline Estimates 20Step 6: Market Forecast and Analysis 21Step 7: Identify Strategic Opportunities 23Step 8: Final Review and Market Release 24Step 9: Customer Feedback and Market Monitoring 25


2.1 BASIC ANATOMY 262.1.1 Urinary System Male Urinary System Female Urinary System 282.2 DISEASE TREATMENT AND DIAGNOSTICS 292.2.1 Benign Prostatic Hyperplasia 292.2.2 Urinary Incontinence 312.2.3 Urinary Tract Infections 332.2.4 Kidney Stones 342.2.5 Bladder Prolapse 362.2.6 Overactive Bladder 372.2.7 Prostatitis 382.2.8 Erectile Dysfunction 402.2.9 Cancer 422.2.9.1 Prostate Cancer 422.2.9.2 Bladder Cancer 432.2.10 Indications for Pelvic Organ Prolapse Repair 45 PRODUCT ASSESSMENT 3.1 INTRODUCTION 463.2 PRODUCT PORTFOLIOS 463.2.1 Urinary Incontinence 463.2.1.1 Urinary Catheters 463. Intermittent Catheters 463. Foley Catheters 473. Male External Catheters 483.2.1.2 Urethral Bulking Agents 493.2.1.3 Incontinence Management Devices 503. Female Incontinence Slings 503. Male Implantable Devices 513.2.1.4 Urine Bags 533. Leg Bags 533. Night Bags 533.2.2 Pelvic Organ Prolapse Repair 583.2.2.1 Autologous tissue as an alternative to vaginal mesh 593.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 603.2.3 Stone Management 613.2.3.1 ESWL Equipment 613.2.3.2 ISWL Equipment 623.2.3.3 Holmium Lasers 623.2.3.4 Stone Fragment Retrieval Devices 633.2.3.5 Ureteral Stents 633.2.4 BPH Treatment 673.2.4.1 TURP 673.2.4.2 TUMT 683.2.4.3 TUNA 683.2.4.4 Prostatic Stents 693.2.4.5 Laser BPH 703. Photoselective Vaporization of the Prostate (PVP) 713. Laser Vaporization of the Prostate 723. Laser Ablation of the Prostate 733. Laser Resection of the Prostate 733. Laser Enucleation of the Prostate 743.2.5 Erectile Dysfunction 763.2.5.1 Penile Implants 763. Inflatable 763. Malleable 773.2.5.2 Vacuum 773.3 REGULATORY ISSUES AND RECALLS 793.3.1 Boston Scientific 793.3.1.1 Stone Management 793.3.1.2 Nephrostomy 813.3.2 C. R. Bard (Becton Dickinson) 823.3.2.1 Urinary Incontinence 823.3.2.2 Stone Management 873.3.2.3 Urological Endoscopes 873.3.2.4 Prostate Cancer Treatment 873.3.2.5 Nephrostomy 883.3.3 Coloplast 903.3.3.1 Urinary Catheter 903.3.3.2 Erectile Dysfunction 903.3.4 Cook Medical 913.3.4.1 Stone Management 913.3.4.2 Nephrostomy 923.3.5 Elekta 943.3.5.1 Prostate Cancer Treatment 943.3.6 Karl Storz 953.3.6.1 Urological Endoscopes 953.3.7 Olympus 963.3.7.1 Urological Endoscopes 963.4 CLINICAL TRIALS 983.4.1 Boston Scientific 983.4.1.1 Urinary Incontinence 983.4.1.2 BPH Treatment 993.4.1.3 Urological endoscopes 1003.4.1.4 Nephrostomy 1013.4.1.5 Erectile Dysfunction 1023.4.2 C. R. Bard (Becton Dickinson) 1033.4.2.1 Urinary Incontinence 1033.4.2.2 Prostate Cancer Treatment 1053.4.3 Coloplast 1063.4.3.1 Urinary Incontinence 1063.4.4 Cook Medical 1093.4.4.1 Nephrostomy 1093.4.5 Elekta 1113.4.5.1 Prostate Cancer Treatment 1113.4.6 Ethicon 1133.4.6.1 Urinary Incontinence 1133.4.7 Karl Storz 1153.4.7.1 Stone Management 1153.4.7.2 Urological Endoscopes 1173.4.8 LABORIE 1203.4.8.1 Urodynamics 1203.4.9 Medline 1223.4.9.1 Urinary Incontinence 1223.4.10 Olympus 1233.4.10.1 Stone Management 1233.4.10.2 BPH Treatment 1243.4.10.3 Urological Endoscopes 125


4.1 INTRODUCTION 1274.2 CURRENCY EXCHANGE RATE 1294.3 MARKET OVERVIEW 1304.4 TREND ANALYSIS BY SEGMENT 1364.5 DRIVERS AND LIMITERS 1394.5.1 Market Drivers 1394.5.2 Market Limiters 1404.6 COMPETITIVE MARKET SHARE ANALYSIS 1434.7 MERGERS AND ACQUISITIONS 1504.8 COMPANY PROFILES 1524.8.1 Boston Scientific 1524.8.2 C. R. Bard (Becton Dickinson) 1544.8.3 Coloplast 1564.8.4 Cook Medical 1574.8.5 Ethicon (Johnson & Johnson) 1584.8.6 Karl Storz 1594.8.7 LABORIE 1604.8.8 Olympus 1614.9 SWOT ANALYSIS 1634.9.1 Boston Scientific 1644.9.2 C. R. Bard (Becton Dickinson) 1664.9.3 Coloplast 1684.9.4 Cook Medical 1694.9.5 Ethicon (Johnson & Johnson) 1714.9.6 Karl Storz 1724.9.7 LABORIE 1734.9.8 Olympus 174 PROCEDURE NUMBERS 5.1 PROCEDURE OVERVIEW 1765.2 URINARY INCONTINENCE PROCEDURES 1815.2.1 Male Incontinence Management Procedures 1835.2.2 Female Incontinence Management Procedures 1855.3 PELVIC ORGAN PROLAPSE REPAIR 1885.4 STONE MANAGEMENT PROCEDURES 1905.4.1 ESWL Procedures 1935.4.2 Transurethral Procedures 1955.4.3 Ureteral Stent Placement Procedures 1975.4.4 PCNL Procedures 1995.5 BPH PROCEDURES 2015.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204


6.1 INTRODUCTION 2076.2 MARKET OVERVIEW 2096.3 MARKET ANALYSIS AND FORECAST 2146.3.1 Total Urinary Catheter Market 2146.3.1.1 Intermittent Catheter Market 2176.3.1.2 Foley Catheter Market 2196.3.1.3 Male External Catheter Market 2216.3.2 Urethral Bulking Agent 2236.3.3 Total Incontinence Management Device Market 2246.3.3.1 Total Female Incontinence Sling Market 2276. Transvaginal Tape Female Incontinence Sling Market 2326. Transobturator Female Incontinence Sling Market 2346.3.3.2 Total Male Implantable Incontinence Device Market 2366. Male Incontinence Sling Market 2416. Male Artificial Urinary Sphincter Market 2436.4 DRIVERS AND LIMITERS 2456.4.1 Market Drivers 2456.4.2 Market Limiters 2456.5 COMPETITIVE MARKET SHARE ANALYSIS 248 PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 7.1 INTRODUCTION 2537.2 MARKET OVERVIEW 2557.3 MARKET ANALYSIS AND FORECAST 2607.3.1 Total Pelvic Organ Prolapse Repair Device Market 2607.3.2 Transvaginal Mesh Market 2637.3.3 Sacrocolpopexy Mesh Market 2657.4 DRIVERS AND LIMITERS 2677.4.1 Market Drivers 2677.4.2 Market Limiters 2677.5 COMPETITIVE MARKET SHARE ANALYSIS 269


>8.1 INTRODUCTION 2728.2 MARKET OVERVIEW 2758.3 MARKET ANALYSIS AND FORECAST 2818.3.1 ESWL Equipment Market 2818.3.2 ISWL Equipment Market 2848.3.3 Total Holmium Laser Market 2868.3.3.1 Holmium Laser Equipment Market 2898.3.3.2 Holmium Laser Fiber Market 2918.3.4 Total Stone Fragment Retrieval Device Market 2948.3.4.1 Nitinol Stone Fragment Retrieval Device Market 2998.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 3018.3.5 Ureteral Stent Market 3038.3.6 Ureteral Guidewire Market 3058.4 DRIVERS AND LIMITERS 3078.4.1 Market Drivers 3078.4.2 Market Limiters 3088.5 COMPETITIVE MARKET SHARE ANALYSIS 310


9.1 INTRODUCTION 3169.1.1 Treatments 3179.1.2 Comparison of TURP and Laser BPH Procedures 3189.1.3 Emerging Technologies 3189.2 MARKET OVERVIEW 3209.3 MARKET ANALYSIS AND FORECAST 3259.3.1 Total TURP Market 3259.3.1.1 Monopolar Electrode Market 3289.3.1.2 Bipolar Electrode Market 3309.3.2 Total Laser BPH Market 3329.3.2.1 Laser BPH Equipment Market 3359.3.2.2 Laser BPH Fiber Market 3379.3.3 UroLift® Market 3399.3.4 Rezum® Market 3429.4 DRIVERS AND LIMITERS 3439.4.1 Market Limiters 3449.5 COMPETITIVE MARKET SHARE ANALYSIS 347


10.1 INTRODUCTION 35110.1.1 Low Testosterone Pharmaceutical Delivery 35210.2 MARKET OVERVIEW 35310.3 MARKET ANALYSIS AND FORECAST 35810.3.1 Inflatable Erectile Dysfunction Device Market 35810.3.2 Malleable Erectile Dysfunction Device Market 36010.3.3 Vacuum Erectile Dysfunction Device 36210.4 DRIVERS AND LIMITERS 36310.4.1 Market Drivers 36310.4.2 Market Limiters 36310.5 COMPETITIVE MARKET SHARE ANALYSIS 365


The Urology Market Report Suite| Japan | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:
  • BARD
  • Biolitec
  • Boston Scientific
  • Coloplast
  • Convergent
  • Cook Medical
  • Create Medical
  • Direx
  • Dornier MedTech
  • EMS
  • Hogy
  • Hollister
  • Intersan
  • JMS
  • Johnson & Johnson
  • Karl Storz
  • LISA Laser
  • Lumenis
  • Medline
  • Olympus
  • Richard Wolf
  • Shibuya Corporation
  • Siemens
  • Star Medtec
  • Takai
  • Teleflex
  • Terumo
  • Trimedyne
  • Urotech

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology